Author: Aras, Omer; Harmsen, Stefan; Ting, Richard; Sayman, Haluk B
Title: (225)Actinium-labeled prostate-specific membrane antigen targeting peptide induces complete response in a metastatic prostate cancer patient Cord-id: g44m0lfl Document date: 2021_5_31
ID: g44m0lfl
Snippet: Targeted radionuclide therapy has emerged as a promising and potentially curative strategy for high-grade prostate cancer. However, limited data are available on efficacy, quality of life, and pretherapeutic biomarkers. Here, we highlight the case of a patient with prostate-specific membrane antigen (PSMA)-positive metastatic castrate-resistant prostate cancer who displayed complete response to (225)Ac-PSMA-617 after having been resistant to standard-of-care therapy, then initially partially res
Document: Targeted radionuclide therapy has emerged as a promising and potentially curative strategy for high-grade prostate cancer. However, limited data are available on efficacy, quality of life, and pretherapeutic biomarkers. Here, we highlight the case of a patient with prostate-specific membrane antigen (PSMA)-positive metastatic castrate-resistant prostate cancer who displayed complete response to (225)Ac-PSMA-617 after having been resistant to standard-of-care therapy, then initially partially responsive but later resistant to subsequent immunotherapy, and resistant to successive (177)Lu-PSMA-617. In addition, the patient’s baseline germline mutation likely predisposed him to more aggressive disease.
Search related documents:
Co phrase search for related documents- abdominal wall and abscess formation: 1, 2
- abdominal wall and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8
- ac psma treatment and lu psma treatment: 1
Co phrase search for related documents, hyperlinks ordered by date